Results 31 to 40 of about 98,010,213 (261)

Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. [PDF]

, 2006
We systematically reviewed the current understanding of human population immunity against SARS-CoV in different groups, settings and geography. Our meta-analysis, which included all identified studies except those on wild animal handlers, yielded an ...
Donnelly, CA, Hedley, AJ, Ferguson, NM, Ho, LM, Lam, T-H, Ghani, AC, Anderson, RM, Lam, TH, Ho, L-M, Riley, S, Leung, GM, Fraser, C, Lim, WW   +12 more
core   +1 more source

Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects [PDF]

, 2021
Coronavirus Disease 2019 (COVID-19) is a global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While detection of SARS-CoV-2 by polymerase chain reaction with reverse transcription (RT-PCR) is currently used to
Jann C. Ang, Bart J. Harvey, Vasudhevan T. Chetty, Zain Chagla, John G. Kelton, James W. Smith, Ali Zhang, Jane C. Moore, Hannah D. Stacey, Ishac Nazy, Nikola Ivetic, Rumi Clare, Dawn M. E. Bowdish, Angela Huynh, Matthew S. Miller, Donald M. Arnold, Chagla Z, Chetty VT, Arnold DM, Huynh A, Clare R, Ivetic N, Bowdish DME, Harvey BJ, Stacey HD, Nazy I, Moore JC, Kelton JG, Miller MS, Zhang A, Smith JW, Ang JC   +31 more
core   +1 more source

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

Frontiers in Immunology, 2021
COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease.
Darrell O. Ricke
doaj   +1 more source

Descriptive analysis of antibodies concentrations by Elecsys Anti-SARS-CoV-2 S and EliA SARS-CoV-2-Sp1 IgG in the 256 non-infected volunteers included in the study.

, 2022
Descriptive analysis of antibodies concentrations by Elecsys Anti-SARS-CoV-2 S and EliA SARS-CoV-2-Sp1 IgG in the 256 non-infected volunteers included in the study.
Estrella Navarro Martín (14053823), José Miguel Díaz-Iglesias (14053829), Rosa Jiménez Coronado (14053817), Antonio Fernández-Suárez (14053814), Carlos Clavijo Aroca (14053820), Amir Qmega Qmega (14053826)   +5 more
core   +1 more source

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2 [PDF]

JAMIA Open, 2020
Abstract Accurate estimations of the seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 need to properly consider the specificity and sensitivity of the antibody tests. In addition, prior knowledge of the extent of viral infection in a population may also be important for adjusting the estimation of ...
Qunfeng Dong, Xiang Gao
openaire   +2 more sources

SARS-CoV-2 binding antibodies.

, 2021
Antibodies with a solved crystal structures in complex with a SARS-CoV-2 antigen. Antibodies were assigned to their nearest epitope cluster, as defined by Dejnirattisai et al. [28].
Wing Ki Wong (7497026), Charlotte M. Deane (50371), Sarah A. Robinson (11831680), Constantin Schneider (3608681), Claire Marks (8463435), Matthew I. J. Raybould (8463432)   +5 more
core   +1 more source

Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study

Microorganisms, 2021
While severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes serious morbidity and mortality in humans (coronavirus disease 2019, COVID-19), there is an enormous range of disease outcomes following virus exposures.
Robert E. Sealy, Julia L. Hurwitz
doaj   +1 more source

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies [PDF]

, 2021
Anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) nucleoprotein (NP) antibodies were isolated from pig sera using human SARS-CoV-2 NP-immobilized magnetic beads. The binding properties of the isolated antibodies against SARS-CoV-2 NP
김현옥, Soo Jeong Lee, Chang Kyu Lee, Tae-Hun Kim, Jae-Chul Pyun, Jeong Soo Sung, Jaeyong Jung, Hyun Ok Kim, Ji-Hong Bong, Min-Jung Kang   +9 more
core   +1 more source

Guest edited collection serological study of SARS-CoV-2 antibodies in japanese cats using protein-A/G-based ELISA

BMC Veterinary Research, 2022
Background Little is known about the epidemic status of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cats in Japan due to insufficiently reliable seroepidemiological analysis methods that are easy to use in cats. Results We developed a
Ichiro Imanishi, Ryota Asahina, Shunji Hayashi, Jumpei Uchiyama, Masaharu Hisasue, Masahiro Yamasaki, Yoshiteru Murata, Shigeru Morikawa, Tetsuya Mizutani, Masahiro Sakaguchi   +9 more
doaj   +1 more source

Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman

Journal of Infection and Public Health, 2021
Objectives: The primary objective is to determine the prevalence of SARS-CoV-2 antibodies persistence among HCWs and specifically among asymptomatic HCWs.
Khalid Al-Naamani, Issa Al-Jahdhami, Wafa Al-Tamtami, Kawther Al-Amri, Murtadha Al-Khabori, Siham Al Sinani, Elias A. Said, Heba Omer, Hamad Al-Bahluli, Saada Al-Ryiami, Saleh Al-Hakmani, Najat Al-Naamani, Ruqaiya Al-Jahwari, Musheera Al-Hinai, Juhaina AlWahaibi   +14 more
doaj   +1 more source